Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PPM1B | O75688 | 1/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.30 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.30 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.30 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26718289 | 0.96 | RAB9A (0.36) | RAB9ANPC1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL25585274 | 0.96 | RAB9A (0.36) | RAB9ANPC1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL26718299 | 0.83 | RAB9A (0.39) | RAB9ANPC1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL26779366 | 0.80 | RAB9A (0.41) | RAB9ANPC1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL26718282 | 0.78 | RAB9A (0.40) | RAB9ANPC1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL25585235 | 0.78 | RAB9A (0.40) | RAB9ANPC1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL25585168 | 0.76 | RAB9A (0.50) | RAB9ANPC1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL26779020 | 0.75 | RAB9A (0.38) | RAB9ANPC1MEN1ALDH1A1CYP1A2 | |
| SCHEMBL12360315 | 0.74 | NAAA (0.38) | ALDH1A1CYP2C19 | |
| SCHEMBL22510580 | 0.72 | ADRA2A (0.48) | ALDH1A1ABCB11CYP3A4ADRA2BOPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167211-A1 | MONOMER ISOMERIZATION AND POLYMER FLUORINATION FOR SUSTAINABLE DEPOLYMERIZABLE POLYMERS | THE UNIVERSITY OF AKRON | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167211-A1 | MONOMER ISOMERIZATION AND POLYMER FLUORINATION FOR SUSTAINABLE DEPOLYMERIZABLE POLYMERS | PFAS, PARG, MFAP1 | RAB9A 2902/4885NPC1 4113/4885MEN1 941/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.